SPAVENTA ANDREW (Chief Executive Officer) purchased 3.0% of their position (118.47K shares) of SINGULAR GENOMICS SYSTEMS, INC. on the open market
Open‑market purchase worth $49.6K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/20/2023ACC: 0001209191-23-056071
DirectorOfficer10% Owner· Chief Executive Officer
Since May 2021
+118.47K
Net shares
Net buyer
$49.6K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
118.47K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+43.47K
Price / share
$0.41
Trade value
$17.86K
% of position
1.1%
11/16/2023
3.94M→3.99M
Common Stock
Indirect
Shares
+75K
Price / share
$0.42
Trade value
$31.75K
% of position
1.9%
11/17/2023
3.99M→4.06M
Total
Net shares
+118.47K
Net value
$49.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/16/2023 | P · Purchase | +43.47K | $0.41 | $17.86K | 1.1% | 3.94M | 3.99M |
| Common Stock Indirect | 11/17/2023 | P · Purchase | +75K | $0.42 | $31.75K | 1.9% | 3.99M | 4.06M |
| Total | +118.47K | $49.61K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned9.77K
Total
9.77K direct9.77K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 9.77K | Direct |
| Total | 9.77K | 9.77K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported